Allosteric modulators of rhodopsin-like G protein-coupled receptors: Opportunities in drug development

2012 ◽  
Vol 135 (3) ◽  
pp. 292-315 ◽  
Author(s):  
Christa E. Müller ◽  
Anke C. Schiedel ◽  
Younis Baqi
2003 ◽  
Vol 4 (5) ◽  
pp. 431-441 ◽  
Author(s):  
J. Smit ◽  
C. Vink ◽  
D. Verzijl ◽  
P. Casarosa ◽  
A. Bruggeman ◽  
...  

2011 ◽  
Vol 32 (10) ◽  
pp. 591-600 ◽  
Author(s):  
Julia K. Archbold ◽  
Jack U. Flanagan ◽  
Harriet A. Watkins ◽  
Joseph J. Gingell ◽  
Debbie L. Hay

2004 ◽  
Vol 32 (5) ◽  
pp. 873-877 ◽  
Author(s):  
A. Christopoulos ◽  
L.T. May ◽  
V.A. Avlani ◽  
P.M. Sexton

Allosteric modulators of G-protein-coupled receptors interact with binding sites that are topographically distinct from the orthosteric site recognized by the receptor's endogenous agonist. Allosteric ligands offer a number of advantages over orthosteric drugs, including the potential for greater receptor subtype selectivity and a more ‘physiological’ regulation of receptor activity. However, the manifestations of allosterism at G-protein-coupled receptors are quite varied, and significant challenges remain for the optimization of screening methods to ensure the routine detection and validation of allosteric ligands.


2015 ◽  
Vol 353 (2) ◽  
pp. 246-260 ◽  
Author(s):  
Emma T. van der Westhuizen ◽  
Celine Valant ◽  
Patrick M. Sexton ◽  
Arthur Christopoulos

Sign in / Sign up

Export Citation Format

Share Document